We are live on ! Find out more
KPTI icon

Karyopharm Therapeutics
KPTI

54 hedge funds and large institutions have $204M invested in Karyopharm Therapeutics in 2013 Q4 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+54
Holders Change %
–
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
54
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$43.2M
2
PHS
PFM Health Sciences
California
+$16.4M
3
Franklin Resources
Franklin Resources
California
+$14.5M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.3M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$8.37M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Sectoral Asset Management
Quebec, Canada
$802K +$644K +2,333 New
Deutsche Bank
27
Deutsche Bank
Germany
$756K +$608K +2,202 New
EAM
28
Eventide Asset Management
Massachusetts
$678K +$545K +1,973 New
PIM
29
Partner Investment Management
California
$662K +$555K +2,009 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$617K +$496K +1,796 New
HCMT
31
Highland Capital Management (Texas)
Texas
$595K +$478K +1,730 New
SIM
32
Spark Investment Management
New York
$553K +$446K +1,613 New
Millennium Management
33
Millennium Management
New York
$492K +$395K +1,430 New
TCIM
34
TIAA CREF Investment Management
New York
$471K +$378K +1,369 New
MHP
35
Manatuck Hill Partners
Connecticut
$458K +$368K +1,333 New
BIM
36
BlackRock Investment Management
Delaware
$455K +$365K +1,323 New
N
37
Nuveen
North Carolina
$425K +$342K +1,237 New
Charles Schwab
38
Charles Schwab
California
$385K +$309K +1,118 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$325K +$262K +947 New
NFA
40
Nationwide Fund Advisors
Ohio
$292K +$235K +849 New
TA
41
Teachers Advisors
New York
$253K +$203K +736 New
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$234K +$188K +681 New
SCA
43
SAC Capital Advisors
Connecticut
$221K +$177K +642 New
AIG
44
American International Group
New York
$119K +$95.6K +346 New
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$112K +$92K +333 New
Citigroup
46
Citigroup
New York
$88K +$70.4K +255 New
SO
47
STRS Ohio
Ohio
$71K +$57.2K +207 New
BlackRock
48
BlackRock
New York
$60K +$47.8K +173 New
BJ
49
BlackRock Japan
Japan
$31K +$24.6K +89 New
US Bancorp
50
US Bancorp
Minnesota
$29K +$23.5K +85 New
1
2
3

KPTI Hedge Fund Activity: Q4 2013 in Review

54 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Karyopharm Therapeutics (KPTI) for Q4 2013, worth a combined $204M.

Buyers outnumbered sellers: 54 funds opened new KPTI positions and 0 closed out — a net gain of 54 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $43.2M.

  • 54 institutional investors held Karyopharm Therapeutics (KPTI) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $204M of Karyopharm Therapeutics stock for Q4 2013.
  • 54 funds opened new Karyopharm Therapeutics positions in Q4 2013 and 0 closed out, a net change of +54 holders.
  • The largest Karyopharm Therapeutics buyer in Q4 2013 was Fidelity Investments, an estimated $43.2M added.

Based on aggregated 13F filings for Q4 2013.